bioRxivBioinformaticsPreprint
Theoretical Insights from Binding of Neigleria fowleri Cell Division Proteins with Amoebicidal Quassinoids
Abstract
The ameboflagellate Neigleria fowleri, also known as brain eating amoeba is responsible for fatal primary amoebic meningoencephalitis (PAM) infection in humans. Cell division proteins (CDPs) in N. fowleri have been uncharacterized until now, despite their importance in the initiation of cell division and proliferation of the pathogen. Here, we report characterization and structural assembly of eight such proteins associated with division and docking them with anti-amoebic quassinoid compounds. Quassinoids have been implicated as inhibitors of cell proliferation of amoeboid species as well as tumor cells. Here, they were screened computationally to find interaction mechanism as well as binding energies with CDPs of N. fowleri. The identified inhibitors could play a role in prevention of cell division and hence, stop N. fowleri growth and proliferation during infection. This study supports CDPs as a target for anti-amoebic intervention and identifies quassinoid phytochemical compounds as suitable for optimization into a new therapy against N. fowleri.
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Naegleria fowleri: protein structures to facilitate drug discovery for the deadly, pathogenic free-living amoeba
Kayleigh F. Barrett, Logan M. Tillery, … Wesley C. Van Voorhis A·PLoS ONEPeer-reviewed·Mar 24, 2021
- EdU incorporation to assess cell proliferation and drug susceptibility for the brain-eating amoeba, Naegleria fowleri
E. V. Troth, D. E. Kyle·bioRxiv·Jan 7, 2021
- Enolase inhibitors as therapeutic leads for Naegleria fowleri infection
J. E. Milanes, V. C. Yan, … J. Morris·bioRxiv·Jan 16, 2024
- Inhibition of fatty acid oxidation as a new target to treat Primary Amoebic Meningoencephalitis by repurposing two well-known drugs
M. J. Sarink, A. Verbon, … J. J. van Hellemond·bioRxiv·May 26, 2019
- Differential growth rates and in vitro drug susceptibility to currently used drugs for multiple isolates of Naegleria fowleri
A. C. Russell, D. E. Kyle·bioRxiv·Oct 12, 2021
- Virulence of Naegleria fowleri isolates varies significantly in the mouse model of primary amoebic meningoencephalitis
A. Cassiopeia Russell, Erica Schiff, … Dennis E. Kyle·bioRxiv·May 20, 2025